Your browser doesn't support javascript.
loading
Changes in incidence rates of outcomes of interest in vaccine safety studies during the COVID-19 pandemic.
Xu, Stanley; Hong, Vennis; Sy, Lina S; Glenn, Sungching C; Ryan, Denison S; Morrissette, Kerresa L; Nelson, Jennifer C; Hambidge, Simon J; Crane, Bradley; Zerbo, Ousseny; DeSilva, Malini B; Glanz, Jason M; Donahue, James G; Liles, Elizabeth; Duffy, Jonathan; Qian, Lei.
Afiliação
  • Xu S; Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States. Electronic address: Stan.Xu@kp.org.
  • Hong V; Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States.
  • Sy LS; Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States.
  • Glenn SC; Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States.
  • Ryan DS; Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States.
  • Morrissette KL; Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States.
  • Nelson JC; Kaiser Permanente Washington Health Research Institute, Seattle, WA, United States.
  • Hambidge SJ; Denver Health Ambulatory Care Services, Denver, CO, United States.
  • Crane B; Center for Health Research, Kaiser Permanente Northwest, Portland, OR, United States.
  • Zerbo O; Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California, Oakland, CA, United States.
  • DeSilva MB; HealthPartners Institute, Minneapolis, MN, United States.
  • Glanz JM; Institute for Health Research, Kaiser Permanente Colorado, Denver, CO, United States.
  • Donahue JG; Marshfield Clinic Research Institute, Marshfield, WI, United States.
  • Liles E; Center for Health Research, Kaiser Permanente Northwest, Portland, OR, United States.
  • Duffy J; Immunization Safety Office, Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • Qian L; Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States.
Vaccine ; 40(23): 3150-3158, 2022 05 20.
Article em En | MEDLINE | ID: mdl-35465977
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trombocitopenia / Vacinas / Cataplexia / Paralisia de Bell / COVID-19 / Narcolepsia Tipo de estudo: Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Vaccine Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trombocitopenia / Vacinas / Cataplexia / Paralisia de Bell / COVID-19 / Narcolepsia Tipo de estudo: Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Vaccine Ano de publicação: 2022 Tipo de documento: Article